With approximately 500,000 monthly prescriptions for testosterone replacement therapy drugs, about 6 million annually, the market potential for Xyosted is huge. According to Symphony Health Solutions, 2016 revenue for TRT was $2.3 billion (source: Antares Form 10K). https://seekingalpha.com/article/4112331-antares-pharma-will-october-deliver-triple-play